Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Interim data suggest potential for RG-101 as backbone therapy for HCV

Feb. 18, 2016

GVN launches Zika Task Force to combat the global Zika outbreak

Feb. 18, 2016

Biotron to test its antiviral compounds for activity against Zika virus

Feb. 18, 2016

RB launches a Zika Relief Package in response to the global outbreak

Feb. 18, 2016

Zepatier available in U.S.

Feb. 17, 2016

Biota Pharmaceuticals' BTA-585 granted FDA fast track designation

Feb. 17, 2016

Nanjing Sanhome reports compounds for the treatment of HCV infections

Feb. 17, 2016

Novartis patents antibacterial quinolone derivatives

Feb. 17, 2016

Intramuscular administration of obiltoxaximab well tolerated in healthy adults

Feb. 16, 2016

Gilead Sciences discloses antiviral agents

Feb. 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...